Ben Tran

Ben Tran is an experienced professional in the field of Biologics CMC Regulatory Affairs, currently serving as Associate Director at Gilead Sciences since March 2025. Prior experience includes roles as Director and Associate Director of Process Engineering at ArsenalBio, where leadership involved developing manufacturing processes for CAR T cell-based therapies and overseeing regulatory strategy. At Genentech, Ben held the position of Principal Engineer, responsible for drug substance process development for mRNA and pDNA therapies, contributing to manufacturing support and IND filings. Earlier roles at Stanford University and Merck & Co., Inc. emphasized research and analysis in various scientific domains. Ben holds a Bachelor of Science in Chemical Engineering from Stanford University and is pursuing a Master of Science in Regulatory Sciences at The Johns Hopkins University.